Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.
2.
3.
5.

The calcitonin/calcitonin gene related peptide-alpha gene is not required for 1alpha,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis.

Becklund BR, James BJ, Gagel RF, DeLuca HF.

Arch Biochem Biophys. 2009 Aug 15;488(2):105-8. doi: 10.1016/j.abb.2009.06.015.

PMID:
19563774
6.

Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.

Spach KM, Pedersen LB, Nashold FE, Kayo T, Yandell BS, Prolla TA, Hayes CE.

Physiol Genomics. 2004 Jul 8;18(2):141-51.

PMID:
15138306
7.

Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice.

Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL.

J Neuroimmunol. 1990 Aug;28(3):261-70.

PMID:
2373763
8.

Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3).

Mattner F, Smiroldo S, Galbiati F, Muller M, Di Lucia P, Poliani PL, Martino G, Panina-Bordignon P, Adorini L.

Eur J Immunol. 2000 Feb;30(2):498-508.

9.

Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.

Black JA, Liu S, Hains BC, Saab CY, Waxman SG.

Brain. 2006 Dec;129(Pt 12):3196-208.

PMID:
16931536
10.

Serum anti-myelin antibodies in chronic relapsing experimental allergic encephalomyelitis.

Whitham RH, Nilaver G, Bourdette DN, Seil FJ.

J Neuroimmunol. 1988 May;18(2):155-70.

PMID:
2451682
11.

[1, 25-dihydroxyvitamin D3 promotes the apoptosis of inflammatory cells in acute experimental autoimmune encephalomyelitis: experiment with rats].

Jiao ZM, Fu YH, Fu J, Zhang F, Wang WZ.

Zhonghua Yi Xue Za Zhi. 2008 Aug 26;88(33):2350-4. Chinese.

PMID:
19087699
12.

Suppression of experimental autoimmune encephalomyelitis by 300-315nm ultraviolet light.

Wang Y, Marling SJ, McKnight SM, Danielson AL, Severson KS, Deluca HF.

Arch Biochem Biophys. 2013 Aug 1;536(1):81-6. doi: 10.1016/j.abb.2013.05.010.

PMID:
23747577
13.

Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Berard JL, Wolak K, Fournier S, David S.

Glia. 2010 Mar;58(4):434-45. doi: 10.1002/glia.20935.

PMID:
19780195
14.

Vitamin D Modulates the Expression of IL-27 and IL-33 in the Central Nervous System in Experimental Autoimmune Encephalomyelitis (EAE).

Mohammadi-Kordkhayli M, Ahangar-Parvin R, Azizi SV, Nemati M, Shamsizadeh A, Khaksari M, Moazzeni SM, Jafarzadeh A.

Iran J Immunol. 2015 Mar;12(1):35-49. doi: IJIv12i1A4.

PMID:
25784096
15.

Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin.

Becklund BR, Hansen DW Jr, Deluca HF.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5276-81. doi: 10.1073/pnas.0813312106.

16.

Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.

Teitelbaum D, Aharoni R, Klinger E, Kreitman R, Raymond E, Malley A, Shofti R, Sela M, Arnon R.

Ann N Y Acad Sci. 2004 Dec;1029:239-49.

PMID:
15681762
17.

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

Runia TF, Hop WC, de Rijke YB, Buljevac D, Hintzen RQ.

Neurology. 2012 Jul 17;79(3):261-6. doi: 10.1212/WNL.0b013e31825fdec7.

PMID:
22700811
20.

Supplemental Content

Support Center